Empreendimentos Pague Menos S.A. (PGMN3) Earnings Call Transcripts

13 earnings calls from May 2023 to August 4, 2026

BOVESPA BR Consumer Staples Consumer Staples Distribution and Retail

Empreendimentos Pague Menos S.A.'s Latest Earnings Call - Q1 FY2026

In Q1 2026, Empreendimentos Pague Menos S.A. (PGMN3:BR) reported a revenue increase of 14.4% year-over-year, reaching BRL 2.8 billion, with net income soaring to BRL 55.6 million, a more than 300% increase compared to the previous year. The company's EBITDA also saw a significant rise, reaching BRL 204.7 million, marking a 36.1% increase. Management maintained a positive outlook, signaling continued growth in same-store sales and market share, while also indicating plans for accelerated store openings in the coming quarters.

Reported metrics

MetricValueContext
Revenue BRL 2.8B (beat) vs BRL 2.45B est, +14.4% YoY
Net Income BRL 55.6M (beat) vs BRL 13.8M last year, +300% YoY
EBITDA BRL 204.7M (beat) vs BRL 150M last year, +36.1% YoY
Same-Store Sales Growth 13% (neutral) vs 17% last year, still strong performance
EBITDA Margin 4.9% (positive) vs 4.1% last year, improvement noted
Market Share 6.7% (positive) vs 6.4% last quarter, steady growth

Guidance from management

Management indicated plans to accelerate store openings in the upcoming quarters and maintain a focus on profitability and reducing debt. They expressed confidence in sustaining growth in same-store sales and market share.

What management said

I would just like to add that we have some CRM actions that we can't really disclose right now, but it's our core focus and I'm very passionate about this type of customer, and we have not yet reached the top of our value capture. The growth will continue through new initiatives and new actions that we are undertaking, and we will also maintain the ones that we already have.
— Jonas Neto, Q1 FY2026 earnings call
Well, I read about this in February. They didn't really say anything about the specific period, but it's a huge growth. And of course, this drug will be compounded. So, you're seeing [ Anvisa ] and for these closing compounding pharmacies that already have stocks, but this is very small compared to the total. If you divide the 95 kilograms by the number of milligrams you have in, then it's a huge amount.
— Jonas Neto, Q1 FY2026 earnings call

What analysts pressed on

Analysts raised concerns about the potential impact of changing labor regulations on operational costs and the company's ability to maintain margins. Additionally, there were questions regarding the stability of GLP-1 supply and its effect on future sales.

Main topics on the call

Read the full Empreendimentos Pague Menos S.A. transcript (Q1 FY2026) → Summary generated from the call transcript; every figure above is stated by management on the record.

About Empreendimentos Pague Menos S.A.

Empreendimentos Pague Menos S.A. (PGMN3) is a publicly listed company in the Consumer Staples Distribution and Retail industry, within the Consumer Staples sector. It trades on BOVESPA and is based in BR. EarningsCalls.dev maintains a free, full-text archive of its earnings call transcripts — 13 calls on record spanning May 9, 2023 to August 4, 2026. Every transcript is split into speaker-by-speaker segments with headline metrics, free to read or available through our REST API.

Earnings Call History

EarningsCalls.dev has 13 Empreendimentos Pague Menos S.A. earnings call transcripts on record, spanning May 9, 2023 to August 4, 2026. Based on this history, Empreendimentos Pague Menos S.A. reports quarterly. The most recent call on file is dated August 4, 2026. The full list is below — each row opens the complete, free-to-read transcript.

Ticker
PGMN3
Exchange
BOVESPA
Country
BR
Sector
Consumer Staples
Industry
Consumer Staples Distribution and Retail
Calls on record
13
First call
May 9, 2023
Most recent
August 4, 2026
Reporting cadence
quarterly
Quarter Date
Q2 FY2026 Aug 4, 2026 Read transcript
Q1 FY2026 May 5, 2026 Read transcript
Q4 FY2025 Mar 2, 2026 Read transcript
Q3 FY2025 Nov 4, 2025 Read transcript
Q1 FY2025 May 6, 2025 Read transcript
Q4 FY2024 Mar 11, 2025 Read transcript
Q3 FY2024 Nov 5, 2024 Read transcript
Q2 FY2024 Aug 6, 2024 Read transcript
Q1 FY2024 May 7, 2024 Read transcript
Q4 FY2023 Mar 5, 2024 Read transcript
Q3 FY2023 Nov 7, 2023 Read transcript
Q2 FY2023 Aug 8, 2023 Read transcript
Q1 FY2023 May 9, 2023 Read transcript